GB0001475A
GB0001475D0
(en)
|
2000-01-21 |
2000-01-21 |
Virus strains
|
CN01806743A
CN1418255A
(en)
|
2000-01-21 |
2001-01-22 |
Herpes virus strains for gene therapy
|
JP2001553368A
JP4921669B2
(en)
|
2000-01-21 |
2001-01-22 |
Virus strain
|
CA2398335A
CA2398335C
(en)
|
2000-01-21 |
2001-01-22 |
Herpes virus strains
|
GB0219033A
GB2374873C
(en)
|
2000-01-21 |
2001-01-22 |
Herpes virus strains
|
BRPI0107736A
BRPI0107736B8
(en)
|
2000-01-21 |
2001-01-22 |
hsv1 js1 strain, pharmaceutical composition, and use of an hsv1 js1 strain
|
AT01901288T
ATE282708T1
(en)
|
2000-01-21 |
2001-01-22 |
HERPES VIRUS STRAINS FOR GENE THERAPY
|
CA002398343A
CA2398343A1
(en)
|
2000-01-21 |
2001-01-22 |
Virus strains for the oncolytic treatment of cancer
|
DK01901288T
DK1252322T4
(en)
|
2000-01-21 |
2001-01-22 |
Herpesvirus strain for gene therapy
|
AU2001226951A
AU2001226951B8
(en)
|
2000-01-21 |
2001-01-22 |
Virus strains for the oncolytic treatment of cancer
|
BR0107736-8A
BR0107736A
(en)
|
2000-01-21 |
2001-01-22 |
Use of a non-laboratory virus strain, methods for determining whether a gene has an effect on a phenotype associated with a peripheral and central nervous system disorder or on a peripheral and central nervous system cell to determine whether a gene encodes an antigen associated with a pathogenic infection or cancer, to determine the suitability of a non-laboratory virus strain for modification to a modified strain, to determine whether a gene enhances the anti-tumor effects of a virus, and to produce an oncolytic non-laboratory virus strain. , modified, non-laboratory virus strain, use of a gene, hsv1 js1 strain, pharmaceutical composition, and, methods for treating a tumor in an individual, supplying a gene to an individual and treating or preventing a disorder of the peripheral nervous systems and central
|
EP01901292A
EP1252323B1
(en)
|
2000-01-21 |
2001-01-22 |
Virus strains for the oncolytic treatment of cancer
|
BRPI0107737A
BRPI0107737B8
(en)
|
2000-01-21 |
2001-01-22 |
herpes simplex virus 1 (hsv1), use of hsv1, and pharmaceutical composition
|
EP09014990A
EP2177619A1
(en)
|
2000-01-21 |
2001-01-22 |
HSV strains for the oncolytic treatment of cancer
|
DE60107203T
DE60107203T3
(en)
|
2000-01-21 |
2001-01-22 |
HERPES VIRUSES FOR GENE THERAPY
|
JP2001553367A
JP4810042B2
(en)
|
2000-01-21 |
2001-01-22 |
Herpesvirus strain
|
CNB018067506A
CN1250732C
(en)
|
2000-01-21 |
2001-01-22 |
Virus strains
|
KR1020027009412A
KR100768408B1
(en)
|
2000-01-21 |
2001-01-22 |
Herpes Virus Strains
|
US10/181,692
US7063835B2
(en)
|
2000-01-21 |
2001-01-22 |
Virus strains
|
EP05011798A
EP1568779A1
(en)
|
2000-01-21 |
2001-01-22 |
HSV strains for the oncolytic treatment of cancer
|
IL15067801A
IL150678A0
(en)
|
2000-01-21 |
2001-01-22 |
Herpes virus strains
|
PCT/GB2001/000225
WO2001053505A2
(en)
|
2000-01-21 |
2001-01-22 |
Herpes virus strains for gene therapy
|
EP01901288A
EP1252322B2
(en)
|
2000-01-21 |
2001-01-22 |
Herpes virus strains for gene therapy
|
PT01901288T
PT1252322E
(en)
|
2000-01-21 |
2001-01-22 |
HERPES VIRUS STRETCHES FOR GENE THERAPY
|
IL15067701A
IL150677A0
(en)
|
2000-01-21 |
2001-01-22 |
Virus strains
|
DK01901292T
DK1252323T3
(en)
|
2000-01-21 |
2001-01-22 |
Virus strains for the oncolytic treatment of cancer
|
PCT/GB2001/000229
WO2001053506A2
(en)
|
2000-01-21 |
2001-01-22 |
Virus strains for the oncolytic treatment of cancer
|
CN 200610003779
CN1865449A
(en)
|
2000-01-21 |
2001-01-22 |
Virus strains
|
AT01901292T
ATE312189T1
(en)
|
2000-01-21 |
2001-01-22 |
VIRUS STRAINS FOR ONCOLYTIC TREATMENT OF CANCER
|
US10/181,697
US7223593B2
(en)
|
2000-01-21 |
2001-01-22 |
Herpes virus strains for gene therapy
|
GB0219030A
GB2375113B
(en)
|
2000-01-21 |
2001-01-22 |
A modified, oncolytic, non-laboratory HSV strain and its use in treating cancer
|
AU2695101A
AU2695101A
(en)
|
2000-01-21 |
2001-01-22 |
Virus strains
|
AU26947/01A
AU782659C
(en)
|
2000-01-21 |
2001-01-22 |
Herpes virus strains for gene therapy
|
ES01901292T
ES2254359T3
(en)
|
2000-01-21 |
2001-01-22 |
VIRAL CEPA FOR THE ONCOLITIC TREATMENT OF CANCERES.
|
KR1020027009410A
KR100802403B1
(en)
|
2000-01-21 |
2001-01-22 |
Virus Strains
|
ES01901288T
ES2233600T5
(en)
|
2000-01-21 |
2001-01-22 |
VIRUSES OF HERPES.
|
DE60115600T
DE60115600T2
(en)
|
2000-01-21 |
2001-01-22 |
VIRUSES FOR ONCOLYTIC TREATMENT OF CANCER
|
CNA2009101295146A
CN101560502A
(en)
|
2000-01-21 |
2001-01-22 |
Herpes virus strains for gene therapy
|
ZA200205439A
ZA200205439B
(en)
|
2000-01-21 |
2002-07-08 |
Herpes virus strains.
|
ZA200205470A
ZA200205470B
(en)
|
2000-01-21 |
2002-07-09 |
Virus strains for the oncolytic treatment of cancer.
|
IL150678A
IL150678A
(en)
|
2000-01-21 |
2002-07-10 |
Herpes virus strains
|
IL150677A
IL150677A
(en)
|
2000-01-21 |
2002-07-10 |
Virus strains
|
HK02108579.0A
HK1047451B
(en)
|
2000-01-21 |
2002-11-28 |
A modified, oncolytic, non-laboratory hsv strain and its use in treating cancer
|
HK02108740.4A
HK1047297B
(en)
|
2000-01-21 |
2002-11-30 |
Herpes virus strains
|
US11/372,613
US7537924B2
(en)
|
2000-01-21 |
2006-03-10 |
Virus strains
|
US11/738,807
US8277818B2
(en)
|
2000-01-21 |
2007-04-23 |
Herpes virus strains for gene therapy
|
US12/425,952
US20090220460A1
(en)
|
2000-01-21 |
2009-04-17 |
Virus strains
|
JP2011238257A
JP2012072156A
(en)
|
2000-01-21 |
2011-10-31 |
Virus strain
|
US13/399,868
US20120164108A1
(en)
|
2000-01-21 |
2012-02-17 |
Virus strains
|
US13/600,711
US8680068B2
(en)
|
2000-01-21 |
2012-08-31 |
Herpes virus strains
|
US14/174,521
US20140154215A1
(en)
|
2000-01-21 |
2014-02-06 |
Herpes virus strains
|
US14/175,855
US10301600B2
(en)
|
2000-01-21 |
2014-02-07 |
Virus strains
|
US14/700,036
US20150232812A1
(en)
|
2000-01-21 |
2015-04-29 |
Herpes virus strains
|
JP2015138227A
JP6424145B2
(en)
|
2000-01-21 |
2015-07-10 |
Virus strain
|
LU93101C
LU93101I2
(en)
|
2000-01-21 |
2016-06-08 |
IMLYGIC-TALIMOGENE LAHERPAREPVEC
|
LU93100C
LU93100I2
(en)
|
2000-01-21 |
2016-06-08 |
TALIMOGENE LAHERPAREPVEC AND ITS PHARMACEUTICALLY ACCEPTABLE DERIVATIVES (IMLYGIC)
|
BE2016C033C
BE2016C033I2
(en)
|
2000-01-21 |
2016-06-14 |
|
NL300821C
NL300821I2
(en)
|
2000-01-21 |
2016-06-14 |
|
NL300820C
NL300820I2
(en)
|
2000-01-21 |
2016-06-14 |
|
CY2016020C
CY2016020I2
(en)
|
2000-01-21 |
2016-06-15 |
HERPES VIRUS STRAIN FOR GENE THERAPY
|
FR16C0026C
FR16C0026I2
(en)
|
2000-01-21 |
2016-06-15 |
HERPETIC VIRUS STRAINS FOR GENE THERAPY
|
CY2016021C
CY2016021I1
(en)
|
2000-01-21 |
2016-06-15 |
VIRUS STRAIN FOR THE ONCOLYTIC THERAPY OF CANCER
|
JP2017037827A
JP2017132779A
(en)
|
2000-01-21 |
2017-03-01 |
Virus strain
|
JP2018218735A
JP6644378B2
(en)
|
2000-01-21 |
2018-11-22 |
Virus strain
|
US16/372,800
US20200032218A1
(en)
|
2000-01-21 |
2019-04-02 |
Virus strains
|
US16/376,089
US20200032219A1
(en)
|
2000-01-21 |
2019-04-05 |
Herpes virus strains
|